217 related articles for article (PubMed ID: 11162575)
21. Characterization of the transcriptional regulatory region of the human WT1 gene.
Hofmann W; Royer HD; Drechsler M; Schneider S; Royer-Pokora B
Oncogene; 1993 Nov; 8(11):3123-32. PubMed ID: 8414514
[TBL] [Abstract][Full Text] [Related]
22. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
[TBL] [Abstract][Full Text] [Related]
23. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients.
Weeks JL; Zoraghi R; Beasley A; Sekhar KR; Francis SH; Corbin JD
Int J Impot Res; 2005; 17(1):5-9. PubMed ID: 15538396
[TBL] [Abstract][Full Text] [Related]
24. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
[TBL] [Abstract][Full Text] [Related]
25. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
Sopory S; Kaur T; Visweswariah SS
Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
[TBL] [Abstract][Full Text] [Related]
26. Expression, distribution and regulation of phosphodiesterase 5.
Lin CS; Lin G; Xin ZC; Lue TF
Curr Pharm Des; 2006; 12(27):3439-57. PubMed ID: 17017938
[TBL] [Abstract][Full Text] [Related]
27. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5).
Stacey P; Rulten S; Dapling A; Phillips SC
Biochem Biophys Res Commun; 1998 Jun; 247(2):249-54. PubMed ID: 9642111
[TBL] [Abstract][Full Text] [Related]
28. In cardiac myocytes, cAMP elevation triggers the down-regulation of transcripts and promoter activity for cyclic AMP phosphodiesterase-4A10 (PDE4A10).
McCahill A; Campbell L; McSorley T; Sood A; Lynch MJ; Li X; Yan C; Baillie GS; Houslay MD
Cell Signal; 2008 Nov; 20(11):2071-83. PubMed ID: 18721873
[TBL] [Abstract][Full Text] [Related]
29. Transcription of the rat angiotensin II type 2 receptor gene.
Ichiki T; Kambayashi Y; Inagami T
Biochem Biophys Res Commun; 1996 May; 222(2):566-71. PubMed ID: 8670245
[TBL] [Abstract][Full Text] [Related]
30. Structural characterization of the human interleukin-13 receptor alpha1 gene promoter.
Ise T; Izumi H; Nagatani G; Takano H; Wada M; Kuwano M; Kohno K
Biochem Biophys Res Commun; 1999 Nov; 265(2):387-94. PubMed ID: 10558877
[TBL] [Abstract][Full Text] [Related]
31. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
32. Cloning and functional characterization of the rat alpha2B-adrenergic receptor gene promoter region: Evidence for binding sites for erythropoiesis-related transcription factors GATA1 and NF-E2.
Schaak S; Cussac D; Labialle S; Mignotte V; Paris H
Biochem Pharmacol; 2005 Aug; 70(4):606-17. PubMed ID: 15993847
[TBL] [Abstract][Full Text] [Related]
33. CART gene promoter transcription is regulated by a cyclic adenosine monophosphate response element.
Barrett P; Davidson J; Morgan P
Obes Res; 2002 Dec; 10(12):1291-8. PubMed ID: 12490674
[TBL] [Abstract][Full Text] [Related]
34. Identification and analysis of the human neural polypyrimidine tract binding protein (nPTB) gene promoter region.
Romanelli MG; Lorenzi P; Morandi C
Gene; 2005 Aug; 356():11-8. PubMed ID: 16002244
[TBL] [Abstract][Full Text] [Related]
35. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
36. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
37. Implications of PDE4 structure on inhibitor selectivity across PDE families.
Ke H
Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
[TBL] [Abstract][Full Text] [Related]
38. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
39. The mouse Psma1 gene coding for the alpha-type C2 proteasome subunit: structural and functional analysis, mapping, and colocalization with Pde3b on mouse chromosome 7.
Hopitzan A; Himmelbauer H; Spevak W; Castanon MJ
Genomics; 2000 Jun; 66(3):313-23. PubMed ID: 10873386
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.
Zhu CB; Hewlett WA; Francis SH; Corbin JD; Blakely RD
Eur J Pharmacol; 2004 Nov; 504(1-2):1-6. PubMed ID: 15507214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
